Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches. | Mol Biomed | 2026 | 41772328 | PubTator, text mining | PubMed |
| Hepatic mitochondrial signaling as a systemic hub: inter-organ communication networks in aging and aging-related diseases. | Front Cell Dev Biol | 2026 | 41768994 | PubTator, text mining | PubMed |
| Case Series of Rare Uterine Smooth Muscle Tumors: Diagnostic Challenges and Clinical Implications. | Cureus | 2026 | 41755965 | PubTator, text mining | PubMed |
| Uterine PEComa With Lymphangioleiomyomatosis (LAM)-Like Features: A Case Report. | Case Rep Pathol | 2026 | 41755808 | PubTator, text mining | PubMed |
| Antitumor Activity of the ACC Inhibitor Firsocostat in Breast Cancer Cell Lines: A Proof-of-Concept In Vitro Study. | Pharmaceuticals (Basel) | 2026 | 41754743 | PubTator, text mining | PubMed |
| The Citric Acid Cycle Modulates Neurologic Health and Is a Therapeutic Target of Dietary and Genetic Modification in Metabolic Disease. | Genes (Basel) | 2026 | 41751576 | PubTator, text mining | PubMed |
| An Update on Uterine Smooth Muscle Tumors: Is It a Leiomyoma, a STUMP, or a Leiomyosarcoma? | Biomedicines | 2026 | 41751185 | PubTator, text mining | PubMed |
| Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer. | Curr Oncol | 2026 | 41744893 | PubTator, text mining | PubMed |
| Leaving the Excision Site Open After Complete Excision of a Large Paracervical Leiomyoma With Fumarate Hydratase (FH)-Deficient Morphology May Decrease the Risk of Developing Renal Cell Carcinoma. | Cureus | 2026 | 41710846 | PubTator, text mining | PubMed |
| [Hereditary leiomyomatosis: interdisciplinary management of a clinical case]. | Semergen | 2026 | 41707421 | PubTator, text mining | PubMed |
| Therapeutic Potential of Amyloid-β Interactors in Rapidly Progressive Alzheimer's Disease-An In Silico Study. | Mol Inform | 2026 | 41692408 | PubTator, text mining | PubMed |
| Diel transcriptional dynamics of a marine sponge and its microbiome in a natural environment. | Anim Microbiome | 2026 | 41645277 | PubTator, text mining | PubMed |
| Gliomas with succinate dehydrogenase deficiency: A case series and brief review of the literature of oncometabolite-driven gliomagenesis. | J Neuropathol Exp Neurol | 2026 | 41637165 | PubTator, text mining | PubMed |
| Zinc ions and zinc-embedded carbon quantum dots as competitive inhibitors of fumarase: preferential inhibition of the reverse reaction. | J Mater Chem B | 2026 | 41635260 | PubTator, text mining | PubMed |
| Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) survey. | Virchows Arch | 2026 | 41634405 | PubTator, text mining | PubMed |
| Hallmarks of nuclear metabolism: implications for genome integrity, nuclear signaling, and therapeutic targeting. | NPJ Metab Health Dis | 2026 | 41629581 | PubTator, text mining | PubMed |
| Reversible arginine methylation regulates mitochondrial IDH2 activity: coordinated control by CARM1 and KDM3A/4A. | Cell Death Dis | 2026 | 41629283 | PubTator, text mining | PubMed |
| Dimethyl fumarate as a versatile therapeutic agent: molecular mechanisms and potential clinical applications. | Mol Biol Rep | 2026 | 41627610 | PubTator, text mining | PubMed |
| First identification of the rare FH-Q185R germline mutation in a Chinese HLRCC patient: A case report and literature review. | SAGE Open Med Case Rep | 2026 | 41625142 | PubTator, text mining | PubMed |
| Advances in Renal Cell Carcinoma Diagnosis: A Review on Biomarkers. | Pathobiology | 2026 | 41591977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=3